Remy Cointreau, Pernod Ricard shares hit by China probe of EU brandy
By Steve Goldstein
Shares in leading French makers of spirits plunged on Friday in wake of a Chinese investigation.
Remy Cointreau (FR:RCO) shares plunged 11% and Pernod Ricard stock (FR:RI) fell 5%, after China launched an anti-dumping investigation into brandy imported from the European Union.
According to JPMorgan, Remy generates about 30% of its profit from China, and Pernod generates about 20%.
"Limited info on what the results from such actions could be, butworst case scenario could be of increased tariffs on all EU Brandy, which could result in lower volumes and/or margins in the region," said Olivia Petronilho of JPMorgan in a note.
LVMH Moet Hennessy (FR:MC), whose wine and spirits account for about a tenth of its revenue, saw its stock fall by 2%.
The announcement by China follows the EU probe into China's electric vehicle makers.
The China Ministry of Commerce said it was responding to a complaint made by the domestic brandy industry.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-05-24 0703ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: Q2 Earnings Season Begins With the Banks
-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations